Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
The Journal of Organic Chemistry|August 12, 2006
Stille coupling reactions in the synthesis of hypoxia-selective 3-alkyl-1,2,4-benzotriazine 1,4-dioxide anticancer agentsKarin Pchalek, Michael P HayNature Reviews. Cancer|May 25, 2011
Targeting hypoxia in cancer therapyWilliam R Wilson, Michael P HayAdvances in Experimental Medicine and Biology|November 26, 2013
Hypoxia-directed drug strategies to target the tumor microenvironmentMichael P Hay, Kevin O Hicks, Jingli WangMagnetic Resonance in Chemistry : MRC|August 11, 2006
Complete 1H, 13C and 15N NMR assignment of tirapazamine and related 1,2,4-benzotriazine N-oxidesMaruta Boyd, Michael P Hay, Peter D W BoydBioorganic & Medicinal Chemistry|May 25, 2005
Nitroarylmethylcarbamate prodrugs of doxorubicin for use with nitroreductase gene-directed enzyme prodrug therapyMichael P Hay, William R Wilson, William A DennyChemistry, an Asian Journal|August 23, 2024
Novel Prodrug Strategies for the Treatment of TuberculosisChristine G Kim, Jiney Jose, Michael P Hay, et al.Journal of the American Chemical Society|March 27, 2009
One-electron reduction potential of the neutral guanyl radical in the GC base pair of duplex DNASujata S Shinde, Andrej Maroz, Michael P Hay, et al.Advances in Experimental Medicine and Biology|June 22, 2016
Efficient Protocol for the Identification of Hypoxic Cell RadiosensitisersCho Rong Hong, Jingli Wang, Kevin O Hicks, et al.Chemical Research in Toxicology|November 18, 2003
Enhanced conversion of DNA radical damage to double strand breaks by 1,2,4-benzotriazine 1,4-dioxides linked to a DNA binder compared to tirapazamineRobert F Anderson, Tracy A Harris, Michael P Hay, et al.Molecules (Basel, Switzerland)|April 24, 2019
Studies Towards Hypoxia-Activated Prodrugs of PARP InhibitorsBenjamin D Dickson, Way Wua Wong, William R Wilson, et al.Pageof 7